Clee Medical has been recognized among Switzerland’s most promising startups, ranking #56 in the 2025 Swiss Top 100 Startups. The Swiss Top 100 Startups ranking showcases the country’s most innovative and high-potential young companies. Compiled annually by a jury of leading venture capitalists, investors, and industry experts, the list highlights Switzerland’s thriving startup ecosystem across deep tech, life sciences, and digital innovation.
This recognition marks another important milestone in Clee Medical’s journey to transform neurosurgery through real-time intraoperative imaging and AI-driven navigation. The company’s Neuro Access platform enables surgeons to visualize brain structures and vasculature in unprecedented detail leading to improved safety, precision, and efficiency in the operating room.